Sudarshan Chemical Industries Limited (506655) Earnings Call Transcripts
Sudarshan Chemical Industries Limited's Latest Earnings Call - Q4 FY2026
In Q4 FY '26, Sudarshan Chemical Industries reported a strong performance with an EBITDA of INR 73 crores, surpassing expectations. The company successfully reduced inventory by EUR 29 million and achieved a net debt reduction from INR 934 crores to INR 755 crores. Management provided guidance for FY '27, projecting an EBITDA of EUR 35 million, indicating confidence in operational improvements and value capture initiatives despite ongoing geopolitical challenges affecting raw material costs.
Reported metrics
| Metric | Value |
|---|---|
| Q4 EBITDA | INR 73 crores (beat) |
| Inventory Reduction | EUR 29 million (beat) |
| Net Debt | INR 755 crores (positive) |
| FY '27 EBITDA Guidance | EUR 35 million (positive) |
| RIECO Revenue | INR 268 crores (positive) |
| Legacy Sudarshan Revenue Growth | 8-10% (positive) |
Guidance from management
Management expects to achieve an EBITDA of EUR 35 million for FY '27, with a longer-term goal of EUR 90 million to EUR 100 million over the next 3 to 4 years, driven by integration synergies and value capture initiatives.
What management said
So as I indicated in my presentation, Mr. Nahata that we've been able to reduce EUR 29 million of inventory. And as we navigate this situation, we will see what are the other additional opportunities in the coming year to reduce further inventories.
So these were kind of existing from the very beginning and as we built up the stock. And I think we hope that we are able to further optimize our inventories to the tune of EUR 15 million to EUR 20 million.
What analysts pressed on
Analysts expressed concerns about the impact of rising energy costs and geopolitical issues on production targets and margins. There were questions regarding the sustainability of growth rates and the management's strategy for debt reduction amidst these challenges.
Main topics on the call
- Strong Q4 Performance — Sudarshan reported an EBITDA of INR 73 crores for Q4 FY '26, exceeding the projected EUR 9 million to EUR 10 million. Management noted, "we delivered EUR 11 million of EBITDA," highlighting effective inventory management...
- Inventory Reduction Success — The company successfully reduced inventory by EUR 29 million in Q4, exceeding the target of EUR 20 million. This was a significant achievement as it alleviated pressure on profitability, with management stating, "we hope...
- Debt Reduction — Sudarshan's net debt decreased from INR 934 crores to INR 755 crores, reflecting improved financial health. Management emphasized this as a positive sign for the balance sheet, stating, "this is a positive sign that we a...
- Guidance for FY '27 — Management provided an EBITDA guidance of EUR 35 million for FY '27, indicating confidence in operational improvements. They stated, "we expect to achieve EUR 90 million to EUR 100 million over the next 3 to 4 years as g...
Read the full Sudarshan Chemical Industries Limited transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Sudarshan Chemical Industries Limited
Sudarshan Chemical Industries Limited (506655) is a publicly listed company in the Chemicals industry, within the Materials sector. It trades on BSE and is based in IN. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 24 calls on record spanning February 6, 2020 to May 27, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 24 Sudarshan Chemical Industries Limited earnings call transcripts on record, spanning February 6, 2020 to May 27, 2026. Based on this history, Sudarshan Chemical Industries Limited reports quarterly. The most recent call on file is dated May 27, 2026. The full list is below — each row opens the complete, free-to-read transcript.
| Quarter | Date | |
|---|---|---|
| Q4 FY2026 | May 27, 2026 | Read transcript → |
| Q3 FY2026 | Feb 13, 2026 | Read transcript → |
| Q3 FY2025 | Feb 17, 2025 | Read transcript → |
| Q2 FY2025 | Oct 29, 2024 | Read transcript → |
| M&A Calls | Oct 15, 2024 | Read transcript → |
| Q1 FY2025 | Aug 5, 2024 | Read transcript → |
| Q4 FY2024 | May 21, 2024 | Read transcript → |
| Q3 FY2024 | Feb 5, 2024 | Read transcript → |
| Q2 FY2024 | Nov 6, 2023 | Read transcript → |
| Q1 FY2024 | Aug 9, 2023 | Read transcript → |
| Q4 FY2023 | May 24, 2023 | Read transcript → |
| Q3 FY2023 | Feb 10, 2023 | Read transcript → |
| Q2 FY2023 | Nov 10, 2022 | Read transcript → |
| Q1 FY2023 | Aug 8, 2022 | Read transcript → |
| Q4 FY2022 | May 27, 2022 | Read transcript → |
| Q3 FY2022 | Jan 25, 2022 | Read transcript → |
| Q2 FY2022 | Oct 29, 2021 | Read transcript → |
| Q1 FY2022 | Aug 9, 2021 | Read transcript → |
| Q4 FY2021 | May 31, 2021 | Read transcript → |
| Q3 FY2021 | Jan 29, 2021 | Read transcript → |
| Earnings Calls | Oct 26, 2020 | Read transcript → |
| Q1 FY2021 | Aug 10, 2020 | Read transcript → |
| Q4 FY2020 | Jun 26, 2020 | Read transcript → |
| Q3 FY2020 | Feb 6, 2020 | Read transcript → |